VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,499,237 | -11.4% | 55,713 | -0.9% | 0.94% | -8.7% |
| Q2 2023 | $1,692,724 | -9.6% | 56,218 | -2.9% | 1.02% | -5.2% |
| Q1 2023 | $1,872,903 | +12.9% | 57,895 | 0.0% | 1.08% | +8.4% |
| Q4 2022 | $1,659,271 | +18.9% | 57,895 | 0.0% | 1.00% | +44.9% |
| Q3 2022 | $1,396,000 | +2.4% | 57,895 | +16.3% | 0.69% | +2.2% |
| Q2 2022 | $1,363,000 | -47.7% | 49,771 | -26.8% | 0.67% | -21.1% |
| Q1 2022 | $2,608,000 | +19.7% | 68,000 | 0.0% | 0.85% | +3.8% |
| Q4 2021 | $2,178,000 | +10.2% | 68,000 | +1.4% | 0.82% | +1.2% |
| Q3 2021 | $1,976,000 | -16.2% | 67,062 | -2.7% | 0.81% | -11.7% |
| Q2 2021 | $2,359,000 | +24.1% | 68,945 | +17.9% | 0.92% | +23.3% |
| Q1 2021 | $1,901,000 | -17.1% | 58,488 | -8.1% | 0.75% | -22.1% |
| Q4 2020 | $2,293,000 | -11.3% | 63,653 | -3.6% | 0.96% | -21.9% |
| Q3 2020 | $2,586,000 | +6.7% | 66,041 | 0.0% | 1.23% | -2.2% |
| Q2 2020 | $2,423,000 | +59.2% | 66,041 | 0.0% | 1.26% | +32.5% |
| Q1 2020 | $1,522,000 | -20.3% | 66,041 | +2.1% | 0.95% | -21.0% |
| Q4 2019 | $1,910,000 | – | 64,676 | – | 1.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |